We analysed 50 gastric carcinomas (GCs) to verify whether mutations at coding repeats were associated with microsatellite instability (MSI). The tumors included: ten cases with no MSI, 14 cases with MSI=1 locus, 13 cases with MSI=two loci and 13 cases with MSI53 loci. We investigated coding repeats within the TGF-b RII, IGFIIR, BAX, hMSH6, hMSH3 and BRCA2 genes. The TGF-b RII, IGFIIR, BAX, hMSH6 and hMSH3 repeats were altered in 11 (22%), ®ve (10%), four (8%), 16 (32%) and ®ve (10%) cases respectively. Mutations occurred only in MSI-positive (MSI+) tumors and correlated with increasing MSI levels. No alterations of the BRCA2 repeat were found. Mutations in genes other than hMSH6 were strongly associated to hMSH6 mutations, suggesting a key role of this gene. The non-coding BAT-26 and E-Cadherin 3' UTR poly(A)8/(T)15 repeats were analysed in 44 of the 50 cases. Novel tumor-associated alleles were observed only in MSI-positive GCs and were in most cases associated with mutations at coding repeats. Further investigations with BAT-40 con®rmed that four cases manifested mononucleotide repeat alterations restricted to hMSH6 and one case to TGF-b RII. A subset of tumors with MSI at two or more dinucleotide loci resulted negative for mutations at coding and non-coding mononucleotide repeats.
Introduction
The mechanism(s) by which microsatellite instability (MSI) contributes to cancer are not fully elucidated, but it has been assumed that mismatch repair (MMR) de®ciencies underlying MSI result in mutations of cancer-related genes, and that such mutations are responsible for carcinogenesis and/or tumor progression (Arnheim and Shibata, 1997 and citations therein) . Genes with proven or potential tumor-suppressor function(s) containing mononucleotide runs in their coding sequence are candidates for mutational inactivation in MSI-positive (MSI+) tumors.
The ®rst gene targeted by MMR de®ciencies to be identi®ed in MSI+ gastrointestinal and, more rarely, endometrial cancers, was the transforming growth factor-b type II receptor (TGF-b RII) gene Myero et al., 1995; Chung et al., 1996 Chung et al., , 1997 . MSI-associated TGF-b RII frameshift mutations tend to occur at a poly(A)10 in the 5' half of the cDNA (codons 125 ± 128). Mutations in coding monotonic runs within the IGFIIR and BAX genes were also detected in MSI+ cancers. The IGFIIR is a multifunctional protein, involved in the intracellular tracking of lysosomal enzymes, in the activation of TGFb1, and in the degradation of the insulin-like growth factor II (IGFII) (Dahms et al., 1989; Dennis et al., 1991; Kornfeld et al., 1992) . Mutations in a coding IGFIIR poly(G)8 tract (nucleotides 4089 ± 4096) were identi®ed in MSI+ gastrointestinal and endometrial cancers (Souza et al., 1996; Chung et al., 1997; Ouyang et al., 1997) . BAX, a member of the BCL2 gene family transactivated by p53 in response to DNA damage (Miyashita and Reed, 1995) , encodes a protein that competes with the BCL2 protein in the regulation of cellular responses to death signals. BAX de®ciencies may result in a diminished ability to trigger apoptosis (Oltvai et al., 1993) . Mutations targeting a BAX poly(G)8 at codons 38 ± 41 were found to be frequent in MSI+ gastrointestinal cancers (Rampino et al., 1997; Chung et al., 1997) . In MSI+ gastrointestinal tumors, additional coding mutational targets were identi®ed in a poly(C)8 within the hMSH6 gene at codons 1116 ± 1118 and in a poly(A)8 within the hMSH3 gene at codons 381 ± 383 (Malkhosyan et al., 1996; Chung et al., 1997) . The products of these two MMR genes interact with the hMSH2 protein to form heterodimers with partially redundant functions (Prolla et al., 1996) and it has been suggested that hMSH6 and/or hMSH3 inactivation in cells already de®cient in MMR may accelerate the accumulation of mutations at mononucleotide runs (Perucho, 1996) .
The objective of this study, which analyses GCs of known MSI status identi®ed in an epidemiological case-control study (Buiatti et al., 1991; Ottini et al., 1997) , was to verify associations between MSI at dinucleotide repeats and mutations at coding mononucleotide runs within the TGF-b RII, IGFIIR, BAX, hMSH6 and hMSH3 genes. In addition, we analysed a coding repeat within BRCA2, a tumor-suppressor gene not speci®cally involved in gastric carcinogenesis (Stratton and Wooster, 1996; Casey, 1997) for which inactivation at mononucleotide runs has been documented (Takahashi et al., 1996) . In most tumors we examined the status of BAT-26, a sensitive indicator of instability at sequence repeats Parsons et al., 1995; Hoang et al., 1997) , and of a poly(A)8/(T)15 repeat wihin the 3' UTR of the ECadherin gene. Cases negative for instability at BAT-26 and at the E-Cadherin 3' UTR repeat, but positive for mutations at two or more dinucleotide microsatellites and/or at coding mononucleotide repeats, were further analysed using BAT-40.
Results
To investigate associations between MSI and mutations at coding repeats, we selected 50 primary GCs whose status had been previously assessed at six dinucleotide loci (Ottini et al., 1997) . The series analysed included ten cases with no evidence of MSI, 14 cases with MSI at one locus, and 26 cases with MSI at two or more loci. Coding mononucleotide repeats within the TGF-b RII (codons 125 ± 128), IGFIIR (nucleotides 4089 ± 4096), BAX (codons 38 ± 41), hMSH6 (codons 1116 ± 1118), hMSH3 (codons 381 ± 383) and BRCA2 (nucleotides 1443 ± 1450) genes were ampli®ed by PCR from paired normal and tumor DNAs obtained by microdissection of a single paranembedded section and the sizes of PCR products were compared. Mutations, exempli®ed in Figure 1 (arrows) and reported in Table 1 , were identi®ed by the presence of abnormal bands in tumor DNAs that were not present in normal DNAs Souza et al., 1996; Malkhosyan et al., 1996; Chung et al., 1997) . Paired genotypings of cases positive for alterations were always con®rmed in triplicate experiments.
No mutations in the poly(A)8 repeat within the BRCA2 gene were observed in the 50 GCs analysed. Mutations in the poly(A)10 repeat of the TGF-b RII gene were found in 11/50 cases (22%) and were associated with the presence of MSI at increasing number of dinucleotide loci: in fact, mutations were detected in 2/14 (14%) cases with MSI at one locus, 3/ 13 (23%) cases with MSI at two loci and 6/13 (46%) cases with MSI at three or more loci. Overall, TGF-b RII mutations were observed in 9/26 (35%) of the GCs with MSI at two or more loci, while no mutations were identi®ed in the ten cases with no evidence of MSI.
Mutations of the IGFIIR poly(G)8 were found in 5/ 50 cases (10%), including 2/13 (15%) cases with MSI at two loci and 3/13 (23%) cases with MSI at three or more loci. The analysis of the BAX poly(G)8 revealed mutations in 4/50 cases (8%), including 1/13 (8%) cases with MSI at two loci and 3/13 (23%) cases with MSI at three or more loci. Mutations of the poly(G)8 tracts within the IGFIIR and BAX genes were observed only in GCs with MSI at two or more dinucleotide loci: in fact, 19% (5/26) and 15% (4/26) of the GCs with multiple MSI respectively showed IGFIIR and BAX mutations.
We further investigated the mononucleotide runs within the hMSH6 and hMSH3 genes. The hMSH6 poly(C)8 appeared to be much more frequently mutated than the hMSH3 poly(A)8, resulting the most frequently altered among the coding mutational targets. In fact, hMSH6 was mutated in 16/50 cases (32%), including 4/14 (29%) cases with MSI at one locus, 4/13 (31%) cases with MSI at two loci and 8/13 (61%) cases with MSI at three or more loci. Mutations of hMSH3 were detected in 5/50 cases (10%), respectively with MSI at two loci (1/13 cases, 8%) and three or more loci (4/13 cases, 31%). Overall, among GCs with MSI at two or more loci, 46% (12/ 26) and 19% (5/26) respectively showed hMSH6 and hMSH3 mutations. Mutations in target genes other than hMSH6 were strongly associated with the presence of hMSH6 mutations: in fact, hMSH6 resulted mutated in 9/11 cases with TGF-b RII mutations, in 4/5 cases with IGFIIR mutations, and in all four cases with BAX mutations. Cases with mutations at three or more coding repeats occurred only in the category of cases with MSI at two or more loci.
With regard to clinicopathologic parameters, TGF-b RII mutations were associated with antral tumor location (P50.01), while IGFIIR mutations were associated with female gender (P=0.03). There were no signi®cant associations between mutations at target genes and patients' age, gastric cancer family history, histologic classi®cation and tumor stage.
Mutations in coding mononucleotide repeats consisted in allele contractions, with the exception of case #70, which harbored an expanded IGFIIR allele and biallelic hMSH6 alterations, respectively resulting in allele expansion and allele contraction (Figure 1 ). In the case of TGF-b RII mutations the signal of the upper wild-type allele was markedly diminished relative to that of the matching normal tissue, suggesting double-hit inactivation. With the exception of the above mentioned biallelic inactivation of hMSH6, which was con®rmed by sequence analysis (data not shown), the comparable intensities of the wild-type and mutant alleles suggested that the mutations in the other coding repeats were heterozygous.
BAT-26 and the E-Cadherin 3'UTR poly(A)8/(T)15 repeat could be analysed in 44 of the 50 GCs (Table  1) . Mutations were observed only in MSI+ GCs and, as shown in Figure 1 (arrows), were always allele contractions. Fourteen of the 37 MSI+ cases tested (38%) manifested BAT-26 allele shifts, including 3/14 cases (21%) with MSI at one locus, 3/10 cases (30%) with MSI at two loci, 7/10 cases (70%) with MSI at three loci and the single case with MSI at ®ve out of six loci. Notably, 12/14 cases (86%) with BAT-26 contractions resulted also positive for mutations at coding repeats, including 11 of 14 cases with hMSH6 mutations. Ten of the 37 MSI+ cases tested (27%) manifested allele shifts of the E-Cadherin 3' UTR repeat, including 3/10 cases (30%) with MSI at two loci, 6/10 cases (60%) with MSI at three loci and the single case with MSI at ®ve out of six loci. Sequencing analysis of the cases positive for ECadherin 3' UTR repeat alterations revealed shortening from 2 ± 5 bp in the poly(T)15 run examined (data not shown). The ten cases with mutations of the E-Cadherin 3' UTR repeat were always positive for BAT-26 alterations. Nine of these cases (90%) resulted also positive for mutations at coding repeats, always including hMSH6. The four cases with hMSH6 mutations that were negative for mutations of the non-coding BAT-26, and E-Cadherin repeats and of the other coding repeats (i.e. #57, #75, #79 and #106, Table 1 ) were further evaluated with BAT-40, resulting negative. Case #121, that manifested only hMSH6 mutations, could not be tested for alterations at non-coding mononucleotide repeats because of lack of DNA. The two tumors with TGF-b RII mutations that were negative for mutations of BAT-26, of the E-Cadherin repeat and of the other coding repeats (i.e. #113 and #117, Table 1 ) were similarly reevaluated with BAT-40. Case #113 was positive for a BAT-40 allele contraction, whereas case #117 was con®rmed as negative.
Five of the eight cases that were MSI+ at two or more dinucleotide loci but negative for mutations at the BAT-26 and E-Cadherin repeats and at coding mononucleotide runs (cases #3, #26, #29, #110 and #116, Table 1 ) were also reevaluated with BAT-40, resulting negative for mutations. The other three cases (#25, #105 and #108) could not be tested because paran-embedded blocks were exhausted.
Discussion
We studied 50 GCs selected on the basis of MSI status at dinucleotide loci (Ottini et al., 1997) for mutations at coding repeats within the TGF-b RII, IGFIIR, BAX, hMSH6, hMSH3 and BRCA2 genes, and at noncoding repeats, including BAT-26, the poly(A)8/(T)15 at the 3' UTR of the E-Cadherin gene, and, in speci®c cases, BAT-40.
While a somatic BRCA2 mutation within the poly(A)8 at codons 602 ± 605 was reported to be associated with a somatic hMSH2 mutation in an MSI+ ovarian cancer (Takahashi et al., 1996) , no BRCA2 mutations in the same poly(A)8 were observed in the presently studied GC series. In general, no mononucleotide mutations were identi®ed among the 10 cases with no evidence of MSI at dinucleotide repeats. The TGF-b RII, IGFIIR, BAX, hMSH6 and hMSH3 repeats were altered in 22%, 10%, 8%, 32% and 10% of the 50 cases respectively. Among GCs with MSI at two or more loci, we observed mutations of the TGF-b RII poly(A)10 in 35% of the cases, of the IGFIIR and BAX poly(G)8 runs respectively in 17% and 14% of the cases, and of the hMSH6 poly(C)8 and hMSH3 poly(A)8 respectively in 46% and 21% of the cases. With the exception of seven cases, of which two with mutations limited to TGF-b RII and ®ve to hMSH6, multiple target genes were simultaneously mutated.
In agreement with other recent reports (Zhou et al., 1997; Chung et al., 1997) , we did not observe anticorrespondences between mutations of genes insisting, at least in part, on the same molecular pathway. In particular, mutations in the TGF-b RII and IGFIIR repeats occurred in the same cases, together with alterations at other mononucleotide repeats. With regard to clinico-pathologic parameters, the association of TGF-b RII mutations with antral GC location may re¯ect the association between MSI and antral tumors described in our previous study (Ottini et al., 1997) . The association of IGFIIR mutations with female gender is intriguing but of obscure signi®cance.
Dierently from colorectal cancer Myero et al., 1995; Rampino et al., 1997) , the presently studied GC series showed a high percentage of mutations in the hMSH6 gene relative to the other genes, including IGFIIR and BAX. Indeed, the frequency of TGF-b RII mutations was rather low compared to other studies that examined smaller series of MSI+ gastric cancers, reporting percentages of mutated cases ranging from 50% (3/6) to 91% (10/11) (Ohue et al., 1996; Myero et al., 1995; Chung et al., 1996 Chung et al., , 1997 . In particular, the recent study of Chung et al. (1997) suggested a primary responsibility of TGF-b RII and BAX mutations in driving the growth of MSIpositive gastric cancers, followed by a secondary involvement of hMSH6. Our results, deriving from a population with dierent epidemiological risk factors (Buiatti et al., 1991; Ottini et al., 1997) , rather suggest a key role of hMSH6 in the mutational cascade leading to the progression of MSI+ GCs. In this respect, the report of Akiyama et al. (1997) , implicating an hMSH6 germline mutations in an atypical hereditary nonpolyposis colorectal cancer kindred also suggests a primary role of hMSH6 in gastric carcinogenesis.
Both hMSH3 and hMSH6 contribute to the stabilization of microsatellite sequences and hMSH6 is particularly involved in repairing single base mispairs within mononucleotide runs (Papadopoulos et al., 1995) . In this study, double hMSH3/hMSH6 mutants were relatively frequent and it may be relevant to note that these cases showed MSI at two or more dinucleotide loci and also tended to manifest mutations at other target genes, as well as BAT-26 and ECadherin 3' UTR repeat contractions. Interestingly, case #70, which manifested biallelic hMSH6 inactivation, was positive for mutations of all coding and noncoding mononucleotide repeats analysed, except the hMSH3 and BRCA2 repeats.
These observations are consistent with the model of progressive mutator mutations that drives a cascade of genomic alterations at sequence repeats. Intriguingly, BAT-26 is located just downstream of the GT splice donor site of intron ®ve of the hMSH2 gene and is almost monomorphic in the population, which suggests that variations in its length might interfere with hMSH2 splicing . However, both coding and non-coding mononucleotide repeats, including BAT-26, the E-Cadherin 3' UTR repeat and BAT-40 were negative for mutations in a subset of cases with MSI at two or more dinucleotide loci, suggesting the possible existence of independent pathways controlling mono-and dinucleotide stability in gastric cancer.
Materials and methods

Subjects
Fifty GCs were selected from a series of 108 cases in which the presence of MSI had been assessed at six dinucleotide loci (Ottini et al., 1997) . The criteria for selection mainly took into account MSI-positive status and availability of tissue sections for multiple DNA extractions. We selected most of the cases with MSI at two or more loci, including 13/16 cases with MSI at two loci, 10/11 with MSI at three loci, 2/4 with MSI at four loci and 1/2 with MSI at ®ve loci. We also included a sample of the cases with MSI at one locus (14/19) and of the MSI-negative cases (10/56). The series analysed consisted of 34 male and 16 female GC patients with a mean age of 64.2 years at diagnosis (5 aged 555 years, eight between 55 and 64 years and 26465 years). A ®rst-degree family history positive for gastric cancer was veri®ed for 18 cases.
Pathology
Twenty-eight tumors were localized in the antrum and 22 in other regions of the stomach. The cases were classi®ed according to Lauren's classi®cation (Buiatti et al., 1991) . The series consisted of 21 GC cases of diuse and unclassi®ed histotype and 29 cases of intestinal hystotype. Twenty cases were staged pT1-2 and 30 pT3-4, 12 were pN negative and 38 pN positive. Formalin-®xed, paran-embedded samples were retrieved from the ®les of the Pathology Department, Florence University. Several 5 mm step sections were cut from one representative block for each patient; only one section was stained with hema-toxylin-eosin.
Analyses of mononucleotide repeats
Tumor and normal tissue DNA was extracted from paran-embedded sections as previously described (Ottini et al., 1995 (Ottini et al., , 1997 . DNA extractions and set-up of PCR reactions were performed in a laboratory distinct from that in which ampli®ed DNAs were manipulated. Mutations in mononucleotides runs were analysed using a PCR-based assay, as previously described (Ottini et al., 1995 (Ottini et al., , 1997 . The 73-base pair region encompassing the TGF-b RII poly(A)10 repeat at codons 125 ± 128 was ampli®ed as reported by Parsons et al. (1995) . The IGFIIR poly(G)8 at nucleotides 4089 ± 4096 was analysed by ampli®cation of a 110-base pair region as reported by Souza et al. (1996) . A 94-base pair region encompassing the BAX poly(G)8 at codons 38 ± 41 was ampli®ed as described by Rampino et al. (1997) . The poly(C)8 and poly(A)8 repeats, respectively at codons 1116 ± 1118 of the hMSH6 gene and at codons 381 ± 383 of the hMSH3 gene were ampli®ed as reported by Malkhosyan et al. (1996) . The BRCA2 poly(A)8 at nucleotides 1443 ± 1450 was ampli®ed using the following primers: forward 5'-TCTGTAGCTTTGAAGAATGCAG-3', backward 5'-TGCAAATGTAAGTGGTGCTTC-3'. A 205-base pair region encompassing the E-Cadherin poly(A)8/(T)15 at nucleotides 3153 ± 3160/3205 ± 3219 was ampli®ed using the following primers: forward 5'-ATCA-GAAGGTTCACCCAGCACC-3', backward 5'-CCGATA-GAATGAGACCCTGTC-3'. The primers used for ampli®cation of BAT-26 and BAT-40 were reported by Parsons et al. (1995) . Analyses of mononucleotide repeats were always consistent from at least two dierent DNA extracts, including one extract that had been used for typings at dinucleotide repeats, as previously reported (Ottini et al., 1997) . Direct sequencing of PCR products was performed by using the Sequenase PCR sequencing kit (USB).
